The funding round was backed by Wayra UK, Octopus Ventures, and Macquarie to support the rollout of Raylo Pay.
"There is a clear shift in consumer behaviour and their preference for subscription based payment models. There’s an appetite for more affordable options to purchase great technology and devices. The Raylo team has proven success in delivering on this consumer trend, and we look forward to helping them scale up their platform through our strategic resources and networks."
The travel card provider surpassed its crowdfunding target in under two hours after drawing support from more than 350 private backers.
"There has been phenomenal demand amongst investors, clearly demonstrating the scalability and need for a viable solution to the foreign exchange trap that we’ve all been forced to endure for too long."
The financing round includes backing from Kima Ventures alongside a UKRI award to adapt the digital health coach for older adults.
"Age UK Lewisham and Southwark exists to improve the lives of older people, working towards a future in which all people are valued, safe, and empowered to make choices about their lives."
The pre-IPO financing comes from a cornerstone investor to support affordable mRNA vaccine development and modular manufacturing.
"Normax is on a social mission to redress global healthcare inequity caused by the profiteering pharmaceutical industry. Following the recent €300 million capital commitment in Normax, we plan to deliver research and development of mRNA vaccines for COVID, TB, HIV, and Malaria and deploy modular mRNA Vaccine Factories, ultimately in up to 100 locations. In the event of another public health emergency we are also committed to delivering future mRNA vaccines in 100 days, to help ensure that COVID-19 is the last pandemic we will all suffer through,"